Cite
HARVARD Citation
Aguilar, S. et al. (n.d.). 66PAdapting a prescreening program to match molecular alterations in over 5, 000 patients' tumors with targeted agents and immunotherapies in early clinical trials over the last 8 years. Annals of oncology. p. . [Online].